Экспорт

ID ...... Строительство зерноперерабатывающего комплекса

  • Дата добавления

    29.07.2012
  • Последнее обновление

    10.05.2023
  • Тип работ

    Новое строительство
  • Производственная площадка

    ········ ········ ·········· ·········· ············
    Объем инвестиций активных проектов: ············ ················ руб.

    Топ-5 активных проектов площадки
    1. ID 157075 Строительство завода фармацевтических субстанций (Подготовка к строительству) (Калужская область, Росва) — 4 млрд руб
    2. ID 157073 Строительство завода готовых лекарственных форм (Подготовка к строительству) (Калужская область, Росва) — 3,5 млрд руб
    3. ID 119717 Строительство завода по производству газобетона (3-я очередь) (Приостановлен на стадии «Подготовка к строительству» в 0 году) (Калужская область, Калуга) — 3 млрд руб
    4. ID 142328 Строительство завода по производству медицинских изделий (Подготовка к строительству) (Калужская область, Росва) — 2 млрд руб
    5. ID 239915 Строительство производства аскорбиновой кислоты (Подготовка к строительству) (Калужская область) — 1,5 млрд руб
  • Краткое описание

    Строительство зерноперерабатывающего комплекса в технопарке "Роста". Будет построен зерноперерабатывающий комплекс мощностью 250 000 тонн пшеницы в год и все необходимые объекты инфраструктуры. Кроме того, новое сельхозпредприятие планирует выпускать глюкозно-фруктовый сироп, коммерческий крахмал, кормовые добавки, сорбит, аскорбиновую кислоту и витамины, являющиеся, что немаловажно, импортозамещающими продуктами. Основными потребителями станут пищевая, фармацевтическая и косметологическая отрасли.
  • Полное описание

    ······ ············ ············ ············ ···· ···· ···· ············ ·········· ················ ·········· ·········· ········ ······ ········ ·············· ···· ······ ···· ········ ···· ······ ············ ·········· ······ ············ ·········· ················ ·············· ············ ·············· ······ ·············· ······ ······ ················ ········ ············ ········ ·········· ········ ········ ·············· ········ ·············· ············ ···· ······ ······ ················ ·············· ········ ················ ············ ············ ················ ········ ················ ········ ········ ·········· ········ ················ ·············· ·············· ············ ········ ···· ·············· ········ ·········· ·········· ···· ········ ············ ······ ········ ···· ······ ········ ················ ········ ················ ············ ················ ·········· ·········· ············ ·············· ········ ···· ············ ················ ················ ············ ······ ········ ···· ············ ············ ·········· ···· ···· ······ ·············· ·············· ·············· ········ ············ ···· ············ ············ ···· ·············· ················ ········ ············ ·············· ········ ·············· ·········· ·········· ········ ······ ······ ················ ······ ···· ·············· ·········· ············ ······ ·············· ·············· ·········· ········ ········ ············ ······ ···· ············ ················ ·············· ·············· ········ ············ ·············· ·········· ···· ················ ·············· ···· ·········· ···· ······ ·············· ···· ········ ················ ·········· ······ ···· ·········· ················ ················ ·········· ············ ············ ···· ······ ············ ······ ···· ······ ············ ········ ········ ················ ···· ········ ·········· ················ ········ ················ ······ ········ ·············· ······ ······ ·············· ·············· ············ ···· ·········· ·············· ···· ·············· ···· ·············· ······ ···· ···· ················ ········ ········ ······ ······ ············ ···· ·············· ···· ········ ······ ················ ·········· ·········· ············ ·············· ············ ···· ················ ················ ···· ······ ············ ······ ············ ········ ········ ················ ················ ···· ······ ········ ·········· ······ ·············· ·········· ········ ···· ···· ················ ········ ·········· ···· ······ ···· ········ ······ ············ ········ ······ ·············· ················ ······ ········ ········ ················ ······ ················ ············ ················ ············ ·············· ·············· ············ ······ ············ ·············· ······ ···· ···· ······ ········ ············ ·············· ···· ········ ············ ················ ······ ······ ············ ············ ················ ···· ········ ········ ·············· ···· ········ ·············· ·············· ················ ················ ······ ········ ···· ················ ············ ·············· ················ ·········· ···· ···· ···· ················ ············ ············ ·············· ······ ············ ············ ·········· ················ ············ ·········· ········ ········ ················ ···· ·············· ·············· ···· ····
  • Результаты интервью

    ···· ·················· ···· ····.····.········ ·············· ························ ·············· ···· ············ ·························· ···················· ·································· ············ ······················ ·················· ·········· ········ ··········

    ···· ·················· ···· ····.····.········ ·························· ·························· ·· ········ ······ ·············· ··················

    ···· ·················· ···· ····.····.········ ······ ·········· ·················· ······ ············ ·················· ···· ············ ····························

    ···· ·················· ···· ····.····.········ ················ ············ ·· ··························

    ···· ·················· ···· ····.····.········ ················ ·········· ······························ ······ ·· ········ ·········· ···· ·· ············ ······ ·········· ·· ························ ······ ·························· ···· ························ ·················· ········ ·················· ···················· ·· ······································ ·················· ············ ········ ···················· ······································ ············ ········ ···················· ········ ·········· ························ ················ ·········· ············ ············ ············

    ···· ·················· ···· ····.····.········ ················ ················ ·· ···························· ·················· ·················· ············ ················ ···· ···················· ·············· ···· ·············· ···················· ·········· ······ ········

  • Объем инвестиций

    ·············· ····

Параметры проекта

  • Площадь объекта

    ······ ······ м2

Отраслевые параметры проекта

Прогноз расхода материала

Материал
Стадия проекта

Инвестор

+ 2

Генеральный проектировщик

+ 3
Контактные лица проекта
Список контактных лиц формируется. Связаться с компанией можно по общему номеру телефона и/или по электронной почте.

Проектировщик

+ 3

Проектировщик

+ 3

Генеральный подрядчик

+ 2
Контактные лица проекта
Список контактных лиц формируется. Связаться с компанией можно по общему номеру телефона и/или по электронной почте.

Субподрядчик

Контактные лица проекта
Список контактных лиц формируется. Связаться с компанией можно по общему номеру телефона и/или по электронной почте.

Производственная площадка (управляющая компания)

Контактные лица проекта
Список контактных лиц формируется. Связаться с компанией можно по общему номеру телефона и/или по электронной почте.
Портал инвестиционных проектов России <http://investprojects.info/projects/newmy?project_id=1433>
Вся информация, размещенная на данном веб-сайте, предназначена только для персонального пользования и не подлежит дальнейшему воспроизведению и / или распространению в какой-либо форме, иначе как с письменного разрешения Инвестиционной группы "Профессиональные Комплексные Решения" (ПКР)
Показать